Skip to main content
Atrás
PBHDF logo

Paramount Bed Holdings Co., Ltd.

Calidad de datos: 100%
Sobreventa
PBHDF
OTC Healthcare Medical - Instruments & Supplies
$19.74
$0.00 (0.00%)
Cap. Mercado: 1.15B
Rango del Día
$19.74 $19.74
Rango de 52 Semanas
—
Volumen
900
Promedio 50D / 200D
— / —
Cierre Anterior
$19.74

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (626 pares)

Métrica Acción Mediana del Sector
P/E 0.1 0.4
P/B 0.0 2.9
ROE % 6.7 3.7
Net Margin % 8.4 3.9
Rev Growth 5Y % 5.6 10.0
D/E 0.1 0.2

Precio Objetivo de Analistas

No hay cobertura de analistas disponible

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2028 $203.99
$203.99 – $203.99
 130 B 1
FY2027 $191.54
$191.54 – $191.54
 120 B 1
FY2026 $180.80
$180.80 – $180.80
 110 B 1

Puntos Clave

Revenue grew 5.64% annually over 5 years — modest growth
Earnings declined -14.49% over the past year
Debt/Equity of 0.05 — conservative balance sheet
Generating 5.99B in free cash flow
P/E of 0.13 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.22%

Crecimiento

Revenue Growth (5Y)
5.64%
Revenue (1Y)2.42%
Earnings (1Y)-14.49%
FCF Growth (3Y)1099.64%

Calidad

Return on Equity
6.65%
ROIC6.75%
Net Margin8.37%
Op. Margin11.95%

Seguridad

Debt / Equity
0.05
Current Ratio3.67
Interest Coverage78.65

Valoración

P/E Ratio
0.13
P/B Ratio0.01
EV/EBITDA-2.08
Dividend Yield0.03%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 2.42% Revenue Growth (3Y) 4.72%
Earnings Growth (1Y) -14.49% Earnings Growth (3Y) -0.72%
Revenue Growth (5Y) 5.64% Earnings Growth (5Y) 1.34%
Profitability
Revenue (TTM) 108.58B Net Income (TTM) 9.08B
ROE 6.65% ROA 4.96%
Gross Margin 48.40% Operating Margin 11.95%
Net Margin 8.37% Free Cash Flow (TTM) 5.99B
ROIC 6.75% FCF Growth (3Y) 1099.64%
Safety
Debt / Equity 0.05 Current Ratio 3.67
Interest Coverage 78.65 Dividend Yield 0.03%
Valuation
P/E Ratio 0.13 P/B Ratio 0.01
P/S Ratio 0.01 PEG Ratio -1.45
EV/EBITDA -2.08 Dividend Yield 0.03%
Market Cap 1.15B Enterprise Value -26.99B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 108.58B 106.02B 99.01B 90.35B 87.17B
Net Income 9.08B 10.62B 9.22B 9.09B 8.61B
EPS (Diluted) 159.24 182.61 158.37 156.39 148.15
Gross Profit 52.56B 50.63B 355.30M 353.51M 365.95M
Operating Income 12.98B 13.82B 13.45B 12.34B 11.58B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 183.03B 180.02B 1.30B 1.35B 1.40B
Total Liabilities 45.74B 44.01B 328.13M 349.99M 366.81M
Shareholders' Equity 137.28B 136.01B 128.70B 121.67B 113.82B
Total Debt 6.81B 5.96B 5.51B 6.14B 7.13B
Cash & Equivalents 34.94B 33.83B 343.71M 373.47M 368.82M
Current Assets 94.53B 95.50B 97.14B 94.04B 86.14B
Current Liabilities 25.76B 24.90B 26.30B 25.39B 23.72B

Puntuaciones de Estrategias

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Deep Value Investing (Seth Klarman)
#428 of 820
41
Value Defensive Investing (Benjamin Graham)
#590 of 708
8

Actividad Reciente

Entró Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entró Defensive Investing (Benjamin Graham)
Mar 24, 2026